1. The change in nationwide seroprevalence of hepatitis C virus and the status of linkage to care in South Korea from 2009 to 2016 2019;13:599-608.
2. Chronic Hepatitis B Infection Is Significantly Associated with Chronic Kidney Disease: a Population-based, Matched Case-control Study. J Korean Mid Sci 2018;33:e264.
3. Hepatitis C virus infection in chronic kidney dis￢ease: paradigm shift in management. Korean J Intern 2018;33:670-678.
4. Development of tenofovir disoproxil fumarate resistance after complete viral suppression in a patient with treatment-naive chronic hepatitis B: A case report and review of the literature. World J Gastroenterol 2018;24:1919-1924.
5. Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study. Clin Mol Hepatol 2018;24:311-318.
6. Pulmonary Lipiodol Embolism Induced by Transarterial Chemoembolization for Hepatocellular Carcinoma. Clin Case Rep Int 2018;2:1060.
7. Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis. BMC Gastroenterol 2017;17:46.
8. Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study. Clin Mol Hepatol 2017;23:51-56.
9. The Performance of Serum Biomarkers for Predicting Fibrosis in Patients with Chronic Viral Hepatitis. Korean J Gasstroenterol 2017;69:298-307.
10. Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis. World J Gastroenterol 2017;23:2396-2403.
11. Acute Kidney Injury in Cirrhotic Patients with Portal Hypertension. Korean J Gastroenterol 2016;68:237-244.
12. Collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma involving the liver: Case report and review of the literature. World J Gastroenterol 2016;22:9229-9234.
13. Sarcomatoid Intrahepatic Cholangiocarcinoma: A Rare Case of Primary Liver Cancer. J Liver Cancer 2016;16:139-144.
14. Clinical Impact of Viral Load on the Development of Hepatocellular Carcinoma and Liver-Related Mortality in Patients with Hepatitis C Virus Infection. Gastroenterol Res Pract 2016;2016:7476231.
15. Vigorous Periprocedural Hydration with Lactated Ringer Solution Reduces the Risk of Pancreatitis After Retrograde Cholangiopancreatography in Hospitalized Patients. Clin Gastroenterol Hepatol 2017;15(1):86-92.
16. 대사증후군과 관련된 비알코올성 지방간염의 실체. Journal of Digestive Diseases 2016:2(2);51-58.
17. Emerging therapeutics and relevant targets for chronic hepatitis B. Turk J Gastroenterol 2016;27:210-215.
18. Daughter cysts in a cyst of the liver: hepatic echinococcosis. Korean J Intern Med 2016;31:197-198.
19. Clinical outcomes of patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective study of routine clinical practice in multi-institutions. BMC Cancer 2015;15:236.
20. B형 간염의 새로운 치료 전략. Journal of Digestive Diseases 2015:1(1);37-42.
21. Risk Factors for Severe Complications in Patients with Esophageal Foreign Bodies. Korean J Med 2015;89(5):537-547.
22. Nutmeg liver cardiac cirrhosis caused by constrictive pericarditis. Korean J Intern 2015;30:938-939.
23. Occult hepatitis B virus infection of hemodialysis patients: A cross-sectional study in a hepatitis B virus-endemic region. Hemodial Int 2015;19:66-71
24. Nonalcoholic Steatohepatitis Associated with Metabolic Syndrome: Relationship to Insulin Resistance and Liver Histology. J Clin Gastroenterol 2014;48:883-888
25. Genome-wide Transcriptional Sequencing Identifies Novel Mutations in Metabolic Genes in Human Hepatocellular Carcinoma. Cancer Genomics & Proteomics 2014;11:1-12
26. Viral hepatitis B: emerging therapies. Clin Mol Hepatol 2014 (KASL STS);25-34
27. A unique bleeding-related complication of sorafenib, a tyrosine kinase inhibitor, a advanced hepatocellular carcinoma: a case report. J Med Case Rep 2014;8:72
28. Early Gastric Cancer with Cellulitis-like Skin Metastasis. Korean J Gastroenterol 2014;63:39-41
29. Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy. World J Gastroenterol 2013;19:8867-8872
30. Clinical Predictors Associated with the Severity of Colonic Diverticulitis. Intest Res 2013;11:23-27.
31. Long-term treatment outcomes of clevudine in antiviral-naive patients with chronic hepatitis B. World J Gastroenterol 2012;18(47):6943-6950
32. NS-398 Induces Caspase-Dependent, Mitochondria-Mediated Intrinsic Apoptosis in Hepatoma Cells. Adv Biosci Biotechnol 2012;3:649-656
33. Prognosis predictability of hepatocellular carcinoma according to staging systems in hepatitis B virus-endemic area. Clin Res Hepatol Gastroenterol 2012;36:357-364
34. Analysis of prognostic factors and 5-year survival rate in patients with hepatocellular carcinoma: a single-center experience. Korean J Hepatol 2012;18:48-55
35. Intramural perforation with hematoma of the esophagus. Clin Res Hepatol Gastroenterol 2012;36:101-102
36. Ruptured duodenal varices arising from the main portal vein successfully treated with endoscopic injection sclerotherapy: a case report. Korean J Hepatol 2011;17:321-324
37. 대한민국 중부지역의 A형간염 항체양성률, 예방접종률 및 항체생성률. Korean J Gastroenterol 2011;57:166-172
38. Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma. Hepatology 2010;52:2034-2043
39. Efficacy of initial treatment with clevudine in naive patients with chronic hepatitis B. Korean J Intern Med 2010;25:372-376
40. 내시경초음파를 통해 관찰한 대장 과립세포종 2예. Korean J Gastrointest Endosc 2010;40:280-284
41. Performance of FDG PET/CT in postoperative colorectal cancer patients with a suspected recurrence and a normal CEA level. Nucl Med Commun 2010;31:576-582
42. Molecular targeted therapy in advanced hepatocellular carcinoma: ideal or illusion? Korean J Hepatol 2010;16(Suppl 1)
43. An Ectopic Opening of the Common Bile Duct into the Duodenal Bulb: The Clinical Features and Endoscopic Treatment. Korean J Gastrointest Endosc 2010;40:16-21
44. Current status of liver disease in Korea: Hepatocellular Carcinoma. Korean J Hepatol 2009;15(Suppl 6):S50-S59
45. Phlebosclerotic colitis in a cirrhotic patient with portal hypertension: the first case in Korea. J Korean Med Sci 2009;24:1195-1199
46. Molecular targeting for treatment of advanced hepatocellular carcinoma. Korean J Hepatol 2009;15:299-308
47. Common Bile Duct Obstruction Caused by Tumor Thrombus after Trans-arterial Chemoembolization in a Hepatocellular Carcinoma Patients. Korean J Gastrointest Endosc 2009;38:299-302
48. Clinical, Radiological and Pathological Exploration of Focal Nodular Hyperplasia of Liver Reported in Korea. Korean J Gastroenterol 2008;52:376-383
49. Efficacy of initial treatment with peginterferon alpha-2a versus peginterferon alpha-2b in combination with ribavirin in naive chronic hepatitis C patients living in Daejeon and Chungcheong province in Korea: a comparative study. Korean J Hepatol 2008;14:498-502
50. Down-regulation of survivin in growth inhibition of hepatoma cells induced by selective cyclooxygenase-2 inhibitor. Korean J Hepatol 2008;14:351-359
51. A Case of Hepatocellular Carcinoma Presented as a Huge Intrahepatic Hematoma. Korean J Gastroenterol 2008;51:385-390
52. 만성 B형간염 치료 가이드라인의 비교 및 검토. 대한간학회지 2007;13(suppl 2):52-59
53. Peripheral nitric oxide activity in patients with liver cirrhosis. Korean J Med 2007;73:251-257
54. Molecular pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma. Gut and Liver 2007;1(2):101-117
55. A Case of Early Gastric Adenocarcinoma Mimiking a Submucosal Tumor. Korean J Gastrointest Endosc 2007;35:250-253
56. Chronic hepatitis B in hepatocarcinogenesis. Postgrad Med J 2006; 82:507-515
57. Optimal Cut-off Value of PIVKA-II for Diagnosis of Hepatocellular Carcinoma. Korean J Hepatol 2006;12:404-411
58. A Case of Severe Skin Eruption Caused by Lamivudine in a Patient with Chronic Hepatitis B. Korean J Gastroenterol 2006;48:281-285
59. Development of PCR-ELISA for the Detection of Hepatitis B Virus X Gene Expression and Clinical Application. J Clin Lab Anal 2005;19:139-145
60. 만성 B형 및 C형 바이러스성 간염 치료의 최근 경향. 대한의사협회지 2005;48(5):440-447